{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:04:55Z","timestamp":1774321495922,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s10354-016-0437-2","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T01:58:07Z","timestamp":1454637487000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Positionspapier zur medikamentenassoziierten Osteonekrose des Kiefers (MRONJ)","Position paper on medication-related osteonecrosis of the jaw (MRONJ)"],"prefix":"10.1007","volume":"166","author":[{"given":"B.","family":"Svejda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Muschitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Brandtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Svejda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. W.","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Santler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. P.","family":"Dimai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"437_CR1","unstructured":"AWMF-Register Nr. 007\/091 Klasse: S3 Bisphosphonat-assoziierte Kiefernekrose (BP-ONJ) und andere Medikamenten-assoziierte Kiefernekrosen. Autoren der Leitlinie: K.A. Gr\u00f6tz, Wiesbaden, J.-U. Piesold, Erfurt und B. Al-Nawas, Mainz; aktueller Stand: 04\/2012"},{"key":"437_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","volume":"90","author":"A Barasch","year":"2011","unstructured":"Barasch A, Cunha-Cruz J, Curro FA et al (2011) Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res 90:439\u2013444","journal-title":"J Dent Res"},{"issue":"2","key":"437_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fon.13.211","volume":"10","author":"G Campisi","year":"2014","unstructured":"Campisi G, Fedele S, Fusco V et al (2014) Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol 10(2):257\u2013275","journal-title":"Future Oncol"},{"key":"437_CR4","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.joms.2013.05.014","volume":"71","author":"ER Carlson","year":"2013","unstructured":"Carlson ER, Fleisher KE, Ruggiero SL (2013) Metastatic cancer identified in osteonecrosis specimens of the jaws in patients receiving intravenous bisphosphonate medications. J Oral Maxillofac Surg 71:2077","journal-title":"J Oral Maxillofac Surg"},{"key":"437_CR5","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","volume":"363","author":"A Cheung","year":"2010","unstructured":"Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363:2473\u20132474","journal-title":"N Engl J Med"},{"key":"437_CR6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","volume":"76","author":"C Christodoulou","year":"2009","unstructured":"Christodoulou C, Pervena A, Klouvas G et al (2009) Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone. Oncology 76:209\u2013211","journal-title":"Oncology"},{"issue":"1","key":"437_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2191-1991-2-12","volume":"2","author":"HP Dimai","year":"2012","unstructured":"Dimai HP, Redlich K, Peretz M et al (2012) Economic burden of osteoporotic fractures in Austria J. Health Econ Rev 2(1):12","journal-title":"Health Econ Rev"},{"key":"437_CR8","unstructured":"EU Advisory Body Aims to Reduce Bone Drug Osteonecrosis Risk. Medscape Mar 13, 2015"},{"key":"437_CR9","volume-title":"National study on avascular necrosis of the jaws","author":"Faculty of General Dental Practice (UK)","year":"2012","unstructured":"Faculty of General Dental Practice (UK) (2012) National study on avascular necrosis of the jaws. Faculty of General Dental Practice, London"},{"key":"437_CR10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ncpendmet0348","volume":"2","author":"D Felsenberg","year":"2006","unstructured":"Felsenberg D (2006) Osteonecrosis of the jaw-a potential adverse effect of bisphosphonate treatment. Nat Clin Pract Endocrinol Metab 2:662\u2013663","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"437_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0037-1621677","volume":"21","author":"D Felsenberg","year":"2012","unstructured":"Felsenberg D, Lopez S, Gabbert T et al (2012) Osteonekrose des Kiefers bei Osteoporosepatienten. Osteologie 21:207\u2013212","journal-title":"Osteologie"},{"key":"437_CR12","unstructured":"Geller M et al (2014) Findings from denosumab (Prolia\u00ae) post-marketing safety surveillance for atypical femoral fracture, osteonecrosis of the jaw, severe symptomatic hypocalcemia, and anaphylaxis. ASBMR 2014 FR0388"},{"key":"437_CR13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","volume":"142","author":"JW Hellstein","year":"2011","unstructured":"Hellstein JW, Adler RA, Edwards B et al (2011) Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American dental association council on scientific affairs. J Am Dent Assoc 142:1243\u20131251","journal-title":"J Am Dent Assoc"},{"key":"437_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2010.05771.x","volume":"1218","author":"AO Hoff","year":"2011","unstructured":"Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF (2011) Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Ann NY Acad Sci 1218:47\u201354","journal-title":"Ann NY Acad Sci"},{"key":"437_CR15","first-page":"547","volume":"32","author":"J Iwamoto","year":"2012","unstructured":"Iwamoto J, Yago K, Sato Y et al (2012) Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly Japanese woman with severe osteoporosis. Clin Drug Investig 32:547\u2013553","journal-title":"Clin Drug Investig"},{"issue":"1","key":"437_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA et al; International Task Force on Osteonecrosis of the Jaw (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3\u201323","journal-title":"J Bone Miner Res"},{"key":"437_CR17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3899\/jrheum.100221","volume":"38","author":"AA Khan","year":"2011","unstructured":"Khan AA, Rios LP, Sandor GK et al (2011) Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. J Rheumatol 38:1396\u20131402","journal-title":"J Rheumatol"},{"key":"437_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ID.0b013e3181cec8bc","volume":"19","author":"CY Lee","year":"2010","unstructured":"Lee CY, Suzuki JB (2010) CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study. Implant Dent 19:29","journal-title":"Implant Dent"},{"key":"437_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","volume":"67","author":"S Lehrer","year":"2009","unstructured":"Lehrer S, Montazem A, Ramanathan L et al (2009) Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene. J Oral Maxillofac Surg 67:159\u20131561","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"437_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.oooo.2012.08.439","volume":"114","author":"J Malan","year":"2012","unstructured":"Malan J, Ettinger K, Naumann E et al (2012) The relationship of denosumab pharmacology and osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol 114(6):671\u2013676","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"9","key":"437_CR21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"437_CR22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tripleo.2011.07.004","volume":"112","author":"F Moretti","year":"2011","unstructured":"Moretti F, Pelliccioni GA, Montebugnoli L et al (2011) A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:777\u2013782","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"437_CR23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.joms.2013.11.005","volume":"72","author":"O Ristow","year":"2014","unstructured":"Ristow O, Gerngro\u00df C, Schwaiger M et al (2014) Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis? J Oral Maxillofac Surg 72(5):903\u2013910","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"437_CR24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 72(10):1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"437_CR25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","volume":"102","author":"SL Ruggiero","year":"2006","unstructured":"Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433\u2013441","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"437_CR26","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van PC et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347","journal-title":"Ann Oncol"},{"key":"437_CR27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00520-009-0688-1","volume":"18","author":"P Stockmann","year":"2010","unstructured":"Stockmann P, Vairaktaris E, Wehrhan F et al (2010) Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer 18:449\u2013460","journal-title":"Support Care Cancer"},{"key":"437_CR28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tripleo.2011.04.020","volume":"112","author":"G Subramanian","year":"2011","unstructured":"Subramanian G, Cohen HV, Quek SY (2011) A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide\u2019s potential role in its resolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:744\u2013753","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"437_CR29","doi-asserted-by":"crossref","unstructured":"Toole J (2015) Editorial Osteonecrosis of the jaws. Rheumatology Advance Access published April 14, 2015. doi:10.1093\/rheumatology\/kev094","DOI":"10.1093\/rheumatology\/kev094"},{"issue":"2","key":"437_CR30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cden.2013.12.006","volume":"58","author":"J Uyanne","year":"2014","unstructured":"Uyanne J, Calhoun CC, Le AD (2014) Antiresorptive drug-related osteonecrosis of the jaw. Dent Clin North Am 58(2):369\u2013384","journal-title":"Dent Clin North Am"},{"key":"437_CR31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","volume":"111","author":"F Wilde","year":"2011","unstructured":"Wilde F, Heufelder M, Winter K et al (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111:153\u2013163","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"437_CR32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/hed.21708","volume":"34","author":"A Wutzl","year":"2010","unstructured":"Wutzl A, Pohl S, Sulzbacher I et al (2010) Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws. Head Neck 34:194\u2013200","journal-title":"Head Neck"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-016-0437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-016-0437-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-016-0437-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T04:46:20Z","timestamp":1567572380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-016-0437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s10354-016-0437-2","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}